# SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

> **NCT01718483** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 383 (actual)

## Conditions studied

- Binge Eating Disorder

## Interventions

- **DRUG:** SPD489 (Lisdexamfetamine dimesylate)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01718483
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-26
- **Primary completion:** 2013-09-25
- **Final completion:** 2013-09-25
- **Target enrollment:** 383 (ACTUAL)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718483, "SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01718483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*